Ascent Industries Q3 net sales rise 37.8% year over year

By Reuters News


Overview

  • Specialty chemicals platform's Q3 net sales rose 37.8% yr/yr to $27.1 mln

  • Adjusted EBITDA for Q3 more than doubled from prior year

  • Gross margin fell due to higher material, labor and shipping costs


Outlook

  • Company expects future margin improvement to come from productivity and operating efficiencies

  • Company sees continued growth opportunities from Midwest Graphic Sales acquisition

  • Company prioritizes liquidity, working capital and investment while remaining open to M&A and buybacks


Result Drivers

  • HIGHER VOLUME AND PRICING - Co said sales growth was driven by increased volumes and higher average selling prices

  • COST RECOVERY AND PRODUCTION - Gross profit increase was attributed to higher sales and cost recovery from increased production, partly offset by higher material, labor and shipping costs

  • MIDWEST ACQUISITION - Midwest Graphic Sales contributed to Q3 sales and was described as accretive to earnings excluding corporate allocations


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Sales

$27.10 mln

Q3 Adjusted EBITDA

$3.50 mln

Q3 Gross Margin

26.20%

Q3 Adjusted EBITDA Margin

13.00%


Reuters Recommended Reads

  • Nov 3 - Flavors and fragrances maker IFF's Q3 sales beat; low end of 2026 outlook raised

  • Nov 3 - Specialty chemicals supplier Innospec's Q3 revenue slightly misses estimates

  • Nov 2 - Huntsman Q3 revenue beats estimates on higher sales volumes


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk